Carlos Aurelio Schiavon
Overview
Explore the profile of Carlos Aurelio Schiavon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Cohen R, Pereira T, Aboud C, Petry T, Lopes Correa J, Schiavon C, et al.
EClinicalMedicine
. 2022 Dec;
53:101725.
PMID: 36467457
Background: We compared the albuminuria-lowering effects of Roux-en-Y gastric bypass (RYGB) to best medical treatment in patients with diabetic kidney disease and obesity to determine which treatment is better. Methods:...
3.
Cohen R, Pereira T, Aboud C, Petry T, Lopes Correa J, Schiavon C, et al.
JAMA Surg
. 2020 Jun;
155(8):e200420.
PMID: 32492126
Importance: Early-stage chronic kidney disease (CKD) characterized by microalbuminuria is associated with future cardiovascular events, progression toward end-stage renal disease, and early mortality in patients with type 2 diabetes. Objective:...
4.
Pareek M, Bhatt D, Schiavon C, Schauer P
Circ Res
. 2019 Mar;
124(7):1009-1024.
PMID: 30920920
The global prevalence of overweight and obesity has risen substantially over the past 4 decades and is accompanied by an increasing burden of cardiovascular risk factors such as hypertension. Metabolic...
5.
Schiavon C, Santos R, Santucci E, Noujaim P, Biasi Cavalcanti A, Drager L
Surg Obes Relat Dis
. 2019 Jan;
15(2):211-217.
PMID: 30679036
Background: Although Roux-en-Y gastric bypass (RYGB) results in significant weight loss and cardiometabolic risk factors improvements; there is no consensus whether limb lengths may influence these results. Objective: To evaluate...
6.
Schiavon C, Bersch-Ferreira A, Santucci E, Oliveira J, Torreglosa C, Bueno P, et al.
Circulation
. 2017 Nov;
137(11):1132-1142.
PMID: 29133606
Background: Recent research efforts on bariatric surgery have focused on metabolic and diabetes mellitus resolution. Randomized trials designed to assess the impact of bariatric surgery in patients with obesity and...
7.
Cohen R, Pereira T, Aboud C, Paulo de Paris Caravatto P, Petry T, Lopes Correa J, et al.
BMJ Open
. 2017 Jan;
7(1):e013574.
PMID: 28077412
Introduction: There are several randomised controlled trials (RCTs) that have already shown that metabolic/bariatric surgery achieves short-term and long-term glycaemic control while there are no level 1A of evidence data...
8.
Schiavon C, Drager L, Bortolotto L, Amodeo C, Ikeoka D, Berwanger O, et al.
Curr Atheroscler Rep
. 2016 Jun;
18(8):50.
PMID: 27324638
Obesity and hypertension are growing epidemics in the modern world. Lifestyle changes and medical treatment for obesity have disappointing long-term results and albeit drugs for hypertension are usually very effective,...
9.
Schiavon C, Ikeoka D, de Sousa M, Silva C, Bersch-Ferreira A, de Oliveira J, et al.
BMJ Open
. 2014 Sep;
4(9):e005702.
PMID: 25200559
Introduction: Obesity and overweight are becoming progressively more prevalent worldwide and are independently associated with a significant increase in the risk of cardiovascular diseases. Systemic arterial hypertension is frequently found...
10.
Cohen R, Neto M, Correa J, Sakai P, Martins B, Schiavon C, et al.
J Clin Endocrinol Metab
. 2013 Jan;
98(2):E279-82.
PMID: 23337729
Context: The duodenal-jejunal bypass liner (DJBL) is a device that mimics the intestinal portion of gastric bypass surgery and has been shown to improve glucose metabolism rapidly in obese subjects...